Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Renal disease as a potential compounding factor in carcinogenesis experiments with Cd151-null mice.

Ashman LK.

Oncogene. 2013 Sep 12;32(37):4457. doi: 10.1038/onc.2013.73. Epub 2013 Mar 11. No abstract available.

PMID:
23474759
2.

Renal disease appears not to affect carcinogenesis in CD151-null mice.

Hemler ME, Hoff J, Li Q, Yang XH.

Oncogene. 2013 Sep 12;32(37):4458. doi: 10.1038/onc.2013.79. Epub 2013 Mar 18. No abstract available.

PMID:
23503459
3.

Tetraspanin CD151 plays a key role in skin squamous cell carcinoma.

Li Q, Yang XH, Xu F, Sharma C, Wang HX, Knoblich K, Rabinovitz I, Granter SR, Hemler ME.

Oncogene. 2013 Apr 4;32(14):1772-83. doi: 10.1038/onc.2012.205. Epub 2012 Jul 23.

4.

Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.

Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, Sonnenberg A, Yi Y, Zhou P, Stipp CS, Kaetzel DM, Hemler ME, Yang XH.

Neoplasia. 2012 Aug;14(8):678-89.

5.

Loss of keratins 8 and 18 leads to alterations in α6β4-integrin-mediated signalling and decreased neoplastic progression in an oral-tumour-derived cell line.

Alam H, Kundu ST, Dalal SN, Vaidya MM.

J Cell Sci. 2011 Jun 15;124(Pt 12):2096-106. doi: 10.1242/jcs.073585. Epub 2011 May 24.

6.

A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5.

Winterwood NE, Varzavand A, Meland MN, Ashman LK, Stipp CS.

Mol Biol Cell. 2006 Jun;17(6):2707-21. Epub 2006 Mar 29.

7.

The role of the tetraspanin CD151 in primary keratinocyte and fibroblast functions: implications for wound healing.

Geary SM, Cowin AJ, Copeland B, Baleato RM, Miyazaki K, Ashman LK.

Exp Cell Res. 2008 Jul 1;314(11-12):2165-75. doi: 10.1016/j.yexcr.2008.04.011. Epub 2008 May 3.

PMID:
18534576
8.

CD151 dynamics in carcinoma-stroma interaction: integrin expression, adhesion strength and proteolytic activity.

Hasegawa M, Furuya M, Kasuya Y, Nishiyama M, Sugiura T, Nikaido T, Momota Y, Ichinose M, Kimura S.

Lab Invest. 2007 Sep;87(9):882-92. Epub 2007 Jul 16.

9.

Cellular and molecular changes during mouse skin tumor progression.

Klein-Szanto AJ, Ruggeri B, Bianchi A, Conti CJ.

Recent Results Cancer Res. 1993;128:193-204. Review. No abstract available.

PMID:
8356319
10.

Acrokeratosis verruciformis: malignant transformation.

Dogliotti M, Schmaman A.

Dermatologica. 1971;143(2):95-9. No abstract available.

PMID:
5138952
11.

Dual Role of alpha6beta4 integrin in epidermal tumor growth: tumor-suppressive versus tumor-promoting function.

Raymond K, Kreft M, Song JY, Janssen H, Sonnenberg A.

Mol Biol Cell. 2007 Nov;18(11):4210-21. Epub 2007 Aug 15.

13.
14.

Squamous cell carcinoma arising from giant porokeratosis: a case with extensive metastasis and hypercalcemia.

Sawai T, Hayakawa H, Danno K, Miyauchi H, Uehara M.

J Am Acad Dermatol. 1996 Mar;34(3):507-9. No abstract available.

PMID:
8609268
15.

Squamous cell carcinoma arising from chronic osteomyelitis of the patella.

Patel NM, Weiner SD, Senior M.

Orthopedics. 2002 Mar;25(3):334-6. No abstract available.

PMID:
11918041
16.

Squamous cell carcinoma arising on the sinus of chronic osteomyelitis of tibia.

Chatterjee ND, Kundu S, Ballav A, Bhattacharjee A, Ray D, Mudi A.

J Indian Med Assoc. 1997 Feb;95(2):57-8. No abstract available.

PMID:
9357248
17.

Invasive skin carcinoma--Ras and alpha6beta4 integrin lead the way.

Mercurio AM.

Cancer Cell. 2003 Mar;3(3):201-2. Review.

18.

Genetic ablation of alphav integrins in epithelial cells of the eyelid skin and conjunctiva leads to squamous cell carcinoma.

McCarty JH, Barry M, Crowley D, Bronson RT, Lacy-Hulbert A, Hynes RO.

Am J Pathol. 2008 Jun;172(6):1740-7. doi: 10.2353/ajpath.2008.070700. Epub 2008 May 8.

19.

Malignant change in a verrucous nevus.

Dogliotti M, Frenkel A.

Int J Dermatol. 1978 Apr;17(3):225-7.

PMID:
649251
20.

Squamous cell carcinoma: could it be the most common skin cancer?

Cohn BA.

J Am Acad Dermatol. 1998 Jul;39(1):134-6. No abstract available.

PMID:
9674413

Supplemental Content

Support Center